-
ABOUT USHebei Guangxiang Pharmaceutical Co., Ltd. is specializing in the production of bulk pharmaceuticals, fine pharmaceuticals, intermediate compounds and biopharmaceutical preparations.
-
News CenterAt the forefront of corporate development, we champion the positive energy of the Four Pharmaceutical Companies: fulfilling our duties conscientiously, stepping up to the plate and taking proactive action, embracing new missions, and conducting effective new publicity. In doing so, we aim to enhance the overall competence of our employees, stimulate their enthusiasm, initiative, and creativity, and provide robust ideological guidance and powerful spiritual strength to drive the enterprise forward.
-
INNOVATIONDevelops fine, series, high-end bulk pharmaceutical intermediates and innovative bulk pharmaceutical intermediates with high added value to build variety competition advantages.
-
-
RECRUITGuangxiang has jointly established engineering laboratories, technology research centers and other high-level innovation platforms with CAS, Zhejiang University, Tianjin University and other universities.
-
CONTACTWith stable production, high-quality and reliable service, the company's products have been sold to more than 80 countries such as the United States, the United Kingdom, Germany and the Netherlands
Jin Hongjun, Director of the Hebei Provincial Administration for Market Regulation, Conducts a Research Visit to Guangxiang Pharmaceutical
Category:
TIME：2020-05-29
【SUMMARY】
On the afternoon of May 27, Jin Hongjun, Director of the Hebei Provincial Administration for Market Regulation, conducted a field inspection at Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisiyao Group in the Bohai New Area to review work on workplace safety.
On the afternoon of May 27, Jin Hongjun, Director of the Hebei Provincial Administration for Market Regulation, conducted a field inspection at Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisiyao Group in the Bohai New Area to review work on workplace safety.
Jin Hongjun conducted a detailed briefing with Han Shuqin, Chairperson of Guangxiang Pharmaceutical, on the company’s current production, operations, and workplace safety.
Jin Hongjun stated that the enterprise’s proactive implementation of work-safety measures and its efforts to strengthen awareness of safety red lines have effectively elevated the overall level of work-safety management, a practice that deserves recognition. It is essential to maintain a high degree of attention to work-safety efforts, ensure accountability, and intensify training on work-safety knowledge for all employees and operators, while also reinforcing emergency-response drills. At the same time, close attention must be paid to equipment management and control to resolutely prevent any safety incidents from occurring.
Relevant officials from Cangzhou City and the Cangzhou Bohai New Area attended the research visit.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
E-mail: hbgxzy@hebgxzy.com
Address: The west of Jingliu Road, lingang economic nad technological development zone, cangzhou city, Hebei province
Website
Official WeChat
e-Home
Business License
